科学研究
代表性论文(*通讯作者,#共一)
(1) M. Ju, Z. Zhang, F. Gao, G. Chen, S. Zhao, D. Wang, H. Wang, Y. Yuan, and H. Yao. Intranasal Delivery of circATF7IP siRNA via Lipid Nanoparticles Alleviates LPS-induced Depressive-like Behaviors, Adv Healthc Mater, 2024, 13(30), e2402219. JCR Q1, IF=9.6.
(2) M. Ju, Y. Liu, M. Li, M. Cheng, Y. Zhang, G. Deng, X. Kang and H. Liu. Baicalin improves intestinal microecology and abnormal metabolism induced by high-fat diet, Eur J Pharmacol, 2019, 857, 172457. JCR Q1, IF=4.7.
(3) Y. Wei, X. He, J. Fang, M. Ju*. Spatiotemporal dynamic monitoring of protein conformation changes by super-resolution imaging, Dyes and Pigments, 2025, 236, JCR Q2, IF=4.2.
(4) J. Fang, X. Gao, W Ding, J Wan, M Chang, B Shen*, M Ju*. Tailoring the polarity sensitivity of fluorescence lifetime imaging probes to reveal interplays of mitochondria dysfunction with lipid droplets formation. Sensors and Actuators B-Chemical, 2025, 426, JCR Q1, IF=7.7.
(5) W. Ding, H. Chen, P. Ma, M. Zhang, X. Li, X. Gao, Z. Chen, Y. Gu*, M. Ju*, S. Wu*, B. Shen*. Comprehensive mining of lung adenocarcinoma biomarkers and rational design of functional probes for enhanced diagnostic and therapeutic applications, Sensors and Actuators B-Chemical, 2025, 444. JCR Q1, IF=7.7.
(6) J Zhai, M Zhang, Z Chen, J Fang, M Ju*, B Shen*, X Zhang*. Investigating the interplay between iron-mediated protein aggregation and mitochondrial damage using polarity-sensitive fluorescent lifetime probes, Sensors and Actuators B-Chemical, 2025, 442, JCR Q1, IF=7.7.
(7) Y. Wei, X. Zi, J. Zhai, M. Zhang, J. Li, Z. Sun, M. Ju*, X. Zhang*, B. Shen*. Exploring Endoplasmic Reticulum Dysfunction on Protein Phase Separation Using Viscosity-Sensitive Fluorescent Lifetime Probe,Analytical Chemistry, 2025,97(18), 10038-10045. JCR Q1, IF=6.7.
(8) Y. Zhang#, M. Ju#, S. Chen, W. Yang, Y. Cai, X. Yu, G. Chen, Z. Shen, Y. Bai, H. Ren, Y. Li, L. Shen, J. Li, P. Shi, Y. Yuan, B. Han, and H. Yao. Migration of CD8+ TSCM cells into intestine via PPBP–CXCR2 axis increases host stress susceptibility by inhibiting gut microbiome-derived HVA. Nat Commun, 2025, JCR Q1, IF=15.7